Ulinastatin polypeptides
US11725043B2 · kind B2 · utility
0Cited by
22References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 5, 2021 |
| Grant date | Aug 15, 2023 |
| Priority date | — |
| Expiry date | Apr 20, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/31
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are ulinastatin glycoforms, ulinastatin fusion polypeptides, and related compositions, mixtures, and methods of use, including methods of recombinantly producing ulinastatin polypeptides and treating diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.